Genmedics GmbH

Genmedics provides exceptional resources and expertise in applied gene technology including: Development of anti-infectives; Expression and purification of plasmid DNA, recombinant DNA derived peptides and proteins; Detection and quantification of targets for biofilm formation; Production of heterologuous proteins and industrial enzymes using the food-grade Staphylococcus carnosus

Activity:

- Contract Research
- Research & Development

Product / Technology type(s) covered:

- API / chemicals
- Bio
- Diagnostics
- Drug delivery
- Enzymes
- Pharmaceuticals / Therapeutics
- Proteins
- Technology

Therapeutic targets:

- Dermatology
- Genetics
- Infectious Diseases
- Orthopedics

Markets Covered

a. HeadQuarter: Germany

b. Continent(s) active: Europe , North America , Asia , Australia/New-Zealand , Central/South America , Near/Middle East

c. Countries active: Europe, USA, Japon, Canada, China

Corporate data:

Number of Employees: 11

Turnover:

Amount:	Year:	Currency:
900	2002	Euro

Year founded: 1998

Partners / Alliances: Boehringer Ingelheim
Aventis
Amersham Bioscience